A. Greer
Harvard University
SurgeryInterval (graph theory)DiseaseOvarian cancerDebulkingEpithelial ovarian cancerAdvanced stageSurgical resectionMedicine
4Publications
0Citations
Publications 5
Newest
#2Allison Gockley (Harvard University)H-Index: 10
Last. Michael J. Worley (Harvard University)H-Index: 15
view all 10 authors...
Objective null To evaluate the impact of size and distribution of residual disease after interval debulking surgery on the timing and patterns of recurrence for patients with advanced-stage epithelial ovarian cancer. null Methods null Patient demographics and data on disease treatment/recurrence were collected from medical records of patients with stage IIIC/IV epithelial ovarian cancer who were managed with neoadjuvant chemotherapy/interval debulking surgery between January 2010 and December 20...
Source
#1Allison Gockley (Harvard University)H-Index: 10
#2B.L. Manning-Geist (Harvard University)H-Index: 4
Last. Michael J. Worley (Brigham and Women's Hospital)H-Index: 15
view all 10 authors...
Source
Source
#2Allison GockleyH-Index: 2
Last. Michael J. WorleyH-Index: 15
view all 10 authors...
Source
#1Marcela G. del Carmen (Harvard University)H-Index: 45
#2Rene ParejaH-Index: 2
Last. Laurel W. Rice (UW: University of Wisconsin-Madison)H-Index: 34
view all 7 authors...
Abstract Objectives To investigate the utility of para-aortic lymph node dissection among women undergoing radical hysterectomy and pelvic lymph adenectomy for FIGO Stage IA2-IB2 cervical cancer using the National Cancer Database (NCDB). Methods We identified patients with stage IA2-IB2 squamous cell, adenosquamous, or adenocarcinoma of the cervix diagnosed 2011–2014 in the NCDB. The primary outcome was the negative predictive value of histologically assessed pelvic lymph node status for para-ao...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.